Provided by Tiger Fintech (Singapore) Pte. Ltd.

Regeneron Pharmaceuticals

605.61
+15.612.65%
Post-market: 605.10-0.5100-0.08%19:53 EDT
Volume:1.61M
Turnover:974.86M
Market Cap:65.41B
PE:15.36
High:615.61
Open:600.00
Low:599.08
Close:590.00
Loading ...

Regeneron Pharmaceuticals (NasdaqGS:REGN) Gains Conditional EC Approval For Lynozyfic In Multiple Myeloma

Simply Wall St.
·
29 Apr

Regeneron Pharmaceuticals' Lynozyfic Receives Conditional Approval in Europe for Multiple Myeloma

MT Newswires Live
·
28 Apr

Lynozyfic Approved In European Union For Treatment Of Relapsed/Refractory Multiple Myeloma

Reuters
·
28 Apr

Lynozyfic™ (Linvoseltamab) Approved in the European Union for the Treatment of Relapsed/Refractory Multiple Myeloma

THOMSON REUTERS
·
28 Apr

Lynozyfic™ (linvoseltamab) Approved in the European Union for the Treatment of Relapsed/Refractory Multiple Myeloma

GlobeNewswire
·
28 Apr

Regeneron Pharma Is Maintained at Neutral by Baird

Dow Jones
·
25 Apr

Analysts Conflicted on These Healthcare Names: Regeneron (REGN), Community Health (CYH) and Integer Holdings (ITGR)

TIPRANKS
·
25 Apr

Regeneron Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
25 Apr

Baird Cuts Price Target on Regeneron Pharmaceuticals to $652 From $759

MT Newswires Live
·
25 Apr

Exact Sciences (EXAS) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release

Zacks
·
24 Apr

What Analyst Projections for Key Metrics Reveal About Regeneron (REGN) Q1 Earnings

Zacks
·
24 Apr

BUZZ-Galderma stock climbs on strong Q1 Injectable Aesthetics performance

Reuters
·
24 Apr

Sanofi's quarterly profit beats estimates on Dupixent boost, newer products

Reuters
·
24 Apr

Regeneron Pharma Is Maintained at Buy by Truist Securities

Dow Jones
·
24 Apr

Biotech Stock Roundup: BMY Down on Study Data, Updates From REGN & More

Zacks
·
24 Apr

Truist Adjusts Price Target on Regeneron Pharmaceuticals to $975 From $1,004, Maintains Buy Rating

MT Newswires Live
·
23 Apr

Japan's Nikkei ends at 3-week high on Wall Street rebound, tech boost

Reuters
·
23 Apr

Eli Lilly, Vertex, AbbVie and More Pharma Stocks to Own as Tariffs Loom -- Barrons.com

Dow Jones
·
22 Apr

FACTBOX-How companies are responding to Trump's tariffs

Reuters
·
22 Apr

Analysts Estimate Regeneron (REGN) to Report a Decline in Earnings: What to Look Out for

Zacks
·
22 Apr